OpenURL Connection Search

Select item for more details and to access through your institution.

Response from the International Transporter Consortium.
Published in:
2011
By:
- Lee, Caroline A.;
- Hillgren, Kathleen M.;
- Lei Zhang;
- Polli, Joseph W.
Publication type:
Letter
Membrane transporters in drug development.
Published in:
2010
By:
- Giacomini, Kathleen M.;
- Shiew-Mei Huang;
- Tweedie, Donald J.;
- Benet, Leslie Z.;
- Brouwer, Kim L. R.;
- Xiaoyan Chu;
- Dahlin, Amber;
- Evers, Raymond;
- Fischer, Volker;
- Hillgren, Kathleen M.;
- Hoffmaster, Keith A.;
- Ishikawa, Toshihisa;
- Keppler, Dietrich;
- Kim, Richard B.;
- Lee, Caroline A.;
- Niemi, Mikko;
- Polli, Joseph W.;
- Sugiyama, Yuichi;
- Swaan, Peter W.;
- Ware, Joseph A.
Publication type:
journal article
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection Administration.
Published in:
Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae282
By:
- Teichner, Paula;
- Chamay, Nadine;
- Elliot, Emilie;
- Pascual-Bernáldez, Miguel;
- Merrill, Deanna;
- Garris, Cindy;
- D'Amico, Ronald;
- Felizarta, Cecy;
- Torres, Emma;
- Solingen-Ristea, Rodica Van;
- Baugh, Bryan;
- Patel, Parul;
- Vannappagari, Vani;
- Dakhia, Samia;
- Polli, Joseph W;
- Garside, Louise;
- Grove, Richard;
- Thiagarajah, Shanker;
- Birmingham, Eileen;
- Wyk, Jean van
Publication type:
Article
The Journey to AAPS 2020: a Reflection from Strategic Planning to PharmSci 360.
Published in:
AAPS Journal, 2019, v. 21, n. 1, p. 1, doi. 10.1208/s12248-018-0273-y
By:
- Polli, Joseph W.;
- McCurdy, Christopher R.;
- Wurster, Dale Eric;
- DeSilva, Binodh S.;
- Bak, Annette;
- Bendayan, Reina;
- Meibohm, Bernd;
- Templeton, Allen C.;
- Weiser, William;
- for the AAPS Leadership
Publication type:
Article
Steady-State Brain Concentrations of Antihistamines in Rats.
Published in:
Pharmacology, 2004, v. 72, n. 2, p. 92, doi. 10.1159/000079137
By:
- Doan, Kelly M. Mahar;
- Wring, Stephen A.;
- Shampine, Larry J.;
- Jordan, Kelly H.;
- Bishop, James P.;
- Kratz, John;
- Yang, Eric;
- Serabjit-Singh, Cosette J.;
- Adkison, Kimberly K.;
- Polli, Joseph W.
Publication type:
Article
The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects.
Published in:
British Journal of Clinical Pharmacology, 2008, v. 66, n. 2, p. 233, doi. 10.1111/j.1365-2125.2008.03184.x
By:
- Adkison, Kimberly K.;
- Vaidya, Soniya S.;
- Lee, Daniel Y.;
- Koo, Seok Hwee;
- Li, Linghui;
- Mehta, Amer A.;
- Gross, Annette S.;
- Polli, Joseph W.;
- Lou, Yu;
- Lee, Edmund J. D.
Publication type:
Article
Expression of calmodulin-dependent enzymes in developing rat striatum is not affected by perturbation of dopaminergic systems.
Published in:
Synapse, 1991, v. 9, n. 2, p. 136, doi. 10.1002/syn.890090208
By:
- Polli, Joseph W.;
- Kincaid, Randall L.;
- Torris, John;
- Billingsley, Melvin L.
Publication type:
Article
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus.
Published in:
BMC Pharmacology & Toxicology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/2050-6511-14-26
By:
- Kapur, Anita;
- O'Connor-Semmes, Robin;
- Hussey, Elizabeth K.;
- Dobbins, Robert L.;
- Wenli Tao;
- Hompesch, Marcus;
- Smith, Glenn A.;
- Polli, Joseph W.;
- James Jr., Charles D.;
- Mikoshiba, Imao;
- Nunez, Derek J.
Publication type:
Article
Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus.
Published in:
BMC Pharmacology & Toxicology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/2050-6511-14-25
By:
- Hussey, Elizabeth K.;
- Kapur, Anita;
- O'Connor-Semmes, Robin;
- Tao, Wenli;
- Rafferty, Bryan;
- Polli, Joseph W.;
- James Jr., Charles D.;
- Dobbins, Robert L.
Publication type:
Article
New Frontiers: Approaches to Understand the Mechanistic Basis of Renal Toxicity.
Published in:
Toxicologic Pathology, 2018, v. 46, n. 8, p. 1002, doi. 10.1177/0192623318798599
By:
- Nabity, Mary B.;
- Polli, Joseph W.;
- Vaidya, Vishal;
- Krolewski, Andrzej;
- Glaab, Warren E.
Publication type:
Article
The journey to AAPS 2020: a reflection from strategic planning to PharmSci 360.
Published in:
2018
By:
- Polli, Joseph W.;
- McCurdy, Christopher R.;
- Wurster, Dale Eric;
- DeSilva, Binodh S.;
- Bak, Annette;
- Bendayan, Reina;
- Meibohm, Bernd;
- Templeton, Allen C.;
- Weiser, William;
- for the AAPS Leadership
Publication type:
Editorial
Drug Development Strategy in the United States: An Industrial View of DMPK.
Published in:
Acta Pharmaceutica Hungarica, 2021, v. 91, n. 3/4, p. 103, doi. 10.33892/aph.2021.91.103-105
By:
- POLLI, JOSEPH W.
Publication type:
Article
Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective.
Published in:
Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 573, doi. 10.1002/cpt.2670
By:
- Taskar, Kunal S.;
- Yang, Xinning;
- Neuhoff, Sibylle;
- Patel, Mitesh;
- Yoshida, Kenta;
- Paine, Mary F.;
- Brouwer, Kim L.R.;
- Chu, Xiaoyan;
- Sugiyama, Yuichi;
- Cook, Jack;
- Polli, Joseph W.;
- Hanna, Imad;
- Lai, Yurong;
- Zamek‐Gliszczynski, Maciej
Publication type:
Article
Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective.
Published in:
Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 916, doi. 10.1002/cpt.1222
By:
- Kenna, J. Gerry;
- Lai, Yurong;
- Maher, Jonathan;
- Pak, Y. Anne;
- Pedersen, Jenny M.;
- Polli, Joseph W.;
- Rodrigues, A. David;
- Watkins, Paul B.;
- Yucha, Robert W.;
- Taskar, Kunal S.;
- Battista, Christina;
- Yang, Kyunghee;
- Bourdet, David L.;
- Brouwer, Kim L.R.;
- Brouwer, Kenneth R.;
- Dai, David;
- Funk, Christoph;
- Hafey, Michael J.
Publication type:
Article
Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
Published in:
Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 900, doi. 10.1002/cpt.1115
By:
- Evers, Raymond;
- Brouwer, Kim L.R.;
- Piquette‐Miller, Micheline;
- Polli, Joseph W.;
- Russel, Frans G.M.;
- Sprowl, Jason A.;
- Tohyama, Kimio;
- Ware, Joseph A.;
- Wildt, Saskia N.;
- Xie, Wen
Publication type:
Article
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96.
Published in:
HIV Medicine, 2024, v. 25, n. 3, p. 381, doi. 10.1111/hiv.13588
By:
- Oka, Shinichi;
- Holohan, Vicki;
- Shirasaka, Takuma;
- Choi, Jun Yong;
- Kim, Yeon‐Sook;
- Chamay, Nadine;
- Patel, Parul;
- Polli, Joseph W.;
- Ford, Susan L.;
- Crauwels, Herta;
- Garside, Louise;
- D'Amico, Ronald;
- Latham, Christine;
- van Solingen‐Ristea, Rodica;
- Baugh, Bryan;
- van Wyk, Jean
Publication type:
Article
Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long‐acting cabotegravir and rilpivirine in clinical trials.
Published in:
HIV Medicine, 2023, v. 24, n. 5, p. 568, doi. 10.1111/hiv.13439
By:
- Patel, Parul;
- Ford, Susan L.;
- Baker, Mark;
- Meyer, Claudia;
- Garside, Louise;
- D'Amico, Ronald;
- Van Solingen‐Ristea, Rodica;
- Crauwels, Herta;
- Polli, Joseph W.;
- Seal, Ciara;
- Yagüe Muñoz, Itziar;
- Thiagarajah, Shanker;
- Birmingham, Eileen;
- Spreen, William R.;
- Baugh, Bryan;
- van Wyk, Jean;
- Vannappagari, Vani
Publication type:
Article
Long-Acting Cabotegravir+Rilpivirine Injection Site Reactions: Pooled Week 96 Results.
Published in:
Infection & Chemotherapy, 2022, v. 54, p. 277
By:
- Chamay, Nadine;
- Elliot, Emilie;
- Dakhia, Samia;
- Polli, Joseph W.;
- Garside, Louise;
- Teichner, Paula;
- Thiagarajah, Shanker;
- D’Amico, Ronald;
- Van Solingen-Ristea, Rodica;
- Birmingham, Eileen;
- Baugh, Bryan;
- Van Wyk, Jean Andre;
- Shin-Woo Kim
Publication type:
Article
Asian Phase 3/3b Experience With Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes Through Week 96.
Published in:
Infection & Chemotherapy, 2022, v. 54, p. 275
By:
- Shinichi Oka;
- Holohan, Vicki;
- Takuma Shirasaka;
- Jun Yong Choi;
- Yeon-Sook Kim;
- Chama, Nadine;
- Patel, Parul;
- Polli, Joseph W.;
- Garside, Louise;
- D’Amico, Ronald;
- Talarico, Christine;
- Baugh, Bryan;
- van Wyk, Jean
Publication type:
Article
Outcomes for participants during long-term follow-up after discontinuation of cabotegravir + rilpivirine long-acting in the phase III/IIIB clinical trials.
Published in:
Infection & Chemotherapy, 2022, v. 54, p. S306
By:
- Teichner, Paula;
- Patel, Parul;
- Cenoz Gomis, Santiago;
- Polli, Joseph W.;
- Roberts, Jeremy;
- Barnett, Vincent;
- Birmingham, Eileen;
- D’Amico, Ronald;
- Baugh, Bryan;
- Yeon-Sook Kim;
- Bosse, Matt
Publication type:
Article
PhRMA White Paper on ADME Pharmacogenomics.
Published in:
Journal of Clinical Pharmacology, 2008, v. 48, n. 7, p. 849, doi. 10.1177/0091270008319329
By:
- Williams, J. Andrew;
- Andersson, Tommy;
- Andersson, Tommy B.;
- Blanchard, Rebecca;
- Behm, Martin Otto;
- Cohen, Nadine;
- Edeki, Timi;
- Franc, Monique;
- Hiligren, Kathleen M.;
- Johnson, Keith J.;
- Katz, David A.;
- Milton, Mark N.;
- Murray, Bernard P.;
- Polli, Joseph W.;
- Ricci, Deb;
- Shipley, Lisa A.;
- Vangala, Subrahmanyam;
- Wrighton, Steven A.
Publication type:
Article
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
Published in:
Clinical Infectious Diseases, 2023, v. 77, n. 10, p. 1423, doi. 10.1093/cid/ciad370
By:
- Orkin, Chloe;
- Schapiro, Jonathan M;
- Perno, Carlo F;
- Kuritzkes, Daniel R;
- Patel, Parul;
- DeMoor, Rebecca;
- Dorey, David;
- Wang, Yongwei;
- Han, Kelong;
- Eygen, Veerle Van;
- Crauwels, Herta;
- Ford, Susan L;
- Latham, Christine L;
- Clair, Marty St.;
- Polli, Joseph W;
- Vanveggel, Simon;
- Vandermeulen, Kati;
- D'Amico, Ronald;
- Garges, Harmony P;
- Zolopa, Andrew
Publication type:
Article
The Journey to AAPS 2020: a Reflection from Strategic Planning to PharmSci 360.
Published in:
2018
By:
- Polli, Joseph W.;
- McCurdy, Christopher R.;
- Wurster, Dale Eric;
- DeSilva, Binodh S.;
- Bak, Annette;
- Bendayan, Reina;
- Meibohm, Bernd;
- Templeton, Allen C.;
- Weiser, William
Publication type:
Editorial
Expression of Calmodulin-Dependent Phosphodiesterase, Calmodulin-Dependent Protein Phosphatase, and Other Calmodulin-Binding Proteins in Human SMS-KCNR Neuroblastoma Cells.
Published in:
Journal of Neurochemistry, 1989, v. 52, n. 5, p. 1438, doi. 10.1111/j.1471-4159.1989.tb09191.x
By:
- Pennypacker, Keith R.;
- Kincaid, Randall L.;
- Polli, Joseph W.;
- Billingsley, Melvin L.
Publication type:
Article
Practical dosing guidance for the management of clinician-administered injections of long-acting cabotegravir and rilpivirine.
Published in:
Therapeutic Advances in Infectious Disease, 2023, v. 10, p. 1, doi. 10.1177/20499361231214626
By:
- Patel, Parul;
- Teichner, Paula;
- Elliot, Emilie;
- Boffito, Marta;
- Murray, Milena;
- Polli, Joseph W.;
- Baker, Mark;
- Ford, Susan L.;
- Han, Kelong;
- Russu, Alberto;
- Crauwels, Herta;
- D'Amico, Ronald D.;
- Spreen, William R.;
- van Wyk, Jean
Publication type:
Article
Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials.
Published in:
Journal of Infectious Diseases, 2024, v. 230, n. 1, p. e34, doi. 10.1093/infdis/jiad580
By:
- Elliot, Emilie R;
- Polli, Joseph W;
- Patel, Parul;
- Garside, Louise;
- Grove, Richard;
- Barnett, Vincent;
- Roberts, Jeremy;
- Byrapuneni, Sri;
- Crauwels, Herta;
- Ford, Susan L;
- Solingen-Ristea, Rodica Van;
- Birmingham, Eileen;
- D'Amico, Ronald;
- Baugh, Bryan;
- Wyk, Jean van
Publication type:
Article

Found: 26